Research Seminars

About

Research Seminars gather a small number (20 to 100) of well-established and preferably young investigators to address scientific topics in depth and help break new ground. Research Seminars take place over two days in easy-to-reach European cities. They are scientific Seminars involving recently published work and research in progress. Participation is fully supported by the budget granted by the ERS.

Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening

With the increasing use of newborn screening and the diagnosis of cystic fibrosis in the first weeks of life, researchers have a clear responsibility to develop interventions that will prevent or delay the onset of bronchiectasis that are suitable for use from birth. The Seminar will bring together motivated CF programme directors and leading researchersin order to:

describe the earliest pathophysiological manifestations of cystic fibrosis lung disease
evaluate key early clinical outcome measures
identify critical gaps in knowledge
prioritise suitable targets for randomised clinical trials
address issues of network management and clinical trials design

Download all media

Newborn screening in Europe K. Southern (Liverpool, United Kingdom)
Outcome Measures discussion with a focus on sample sizes D. Ashby (London, United Kingdom)
Infant pulmonary function - Introduction J. Stocks (London, United Kingdom)
Infant pulmonary function - Raised Volume Technique M. Rosenfeld (Seattle, Washington, United States of America)
Infant pulmonary function - Multiple Breath Washout A. Lindblad (Goteborg, Sweden)
Application and interpretation in RCT's J. Stocks (London, United Kingdom)
Bronchoalveolar lavage C. Wainwright (Brisbane, Australia)
Imaging the infant lung F. Long (Columbus, OH, United States of America)
CT safety issues H. Tiddens (Rotterdam, The Netherlands)
Inflammation, infection and early lung damage P. Sly (West Perth, Australia)
Antibiotics in infants A. Bush (London, United Kingdom)
Workshop: Antibiotics A. Bush (London, United Kingdom)
The Childrens' Oncology Group Experience G. Reaman (Bethesda, Md , United States of America)
Estimates of sample sizes D. Ashby (London, United Kingdom)
Medicines for Children - the UK experience R. Smyth (Liverpool, United Kingdom)
Better Medicines for Children - European regulation, European research networks, Funding opportunities P. Arlett (Brussels, Belgium)